Thomas L. Saeli - 13 May 2025 Form 4 Insider Report for ULTRALIFE CORP (ULBI)

Reporting relationship: Director
Issuer ticker: ULBI
Reported as of: 13 May 2025
Net transaction value: +$27,200
SEC form: 4
Accepted by SEC: 14 May 2025, 16:54:27 UTC
Prior SEC filing: 14 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Philip Fain - Attorney-In-Fact for Thomas L. Saeli

Key filing fact

Thomas L. Saeli filed Form 4 for ULTRALIFE CORP (ULBI) on 14 May 2025.

Key facts

This page summarizes Thomas L. Saeli's Form 4 filing for ULTRALIFE CORP (ULBI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 May 2025, 16:54.

Change

Previous filing in this sequence was filed on 14 Jun 2023.
Current net transaction value: +$27,200.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001490099 Primary reporting owner

Saeli Thomas Louis

Relationship: Director
Address: 2000 TECHNOLOGY PARKWAY, NEWARK
Signature: /s/ Philip Fain - Attorney-In-Fact for Thomas L. Saeli
Signature date: 14 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ULBI transaction

Common Stock; $.10 par value

Purchase

Transaction value: $27,200
Shares: +5,000
Change %: +6.2%
Price: $5.44
Shares after: 85,000
Date: 14 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

5,000 shares purchased at an average cost of $5.4400 per share as follows: 2,995 shares purchased on May 13, 2025 at a cost of $5.4316 per share and 2,005 shares purchased on May 14, 2025 at a cost of $5.4525.